Sort   by:  
 Page size 
MetabolomicsEffects of altering serine metabolic pathways and ROS levels on macrolide resistant strains of Streptococcus suis

In this study, we proposed to obtain the differential metabolic pathways before and after the development of macrolide resistance in Streptococcus suis strain ATCC700494 and the macrolide resistant strain obtained by pre-laboratory induction of strain ATCC700794 as the test strains by non-targete...

2022-07-12 | MTBLS4618 | MetaboLights
MetabolomicsAntibiotics create a shift from mutualism to competition in human gut communities with a longer-lasting impact on fungi than bacteria

Background

Antibiotic treatment has a well-established detrimental effect on the gut bacterial composition, but effects on the fungal community are less clear. Bacteria in the lumen of the gastrointestinal tract may limit fungal colonization and invasion. Antibiotic drugs t...

2020-09-28 | MTBLS1846 | MetaboLights
TranscriptomicsThe general mode of translation inhibition by macrolide antibiotics
Macrolides are clinically important antibiotics thought to inhibit bacterial growth by impeding the passage of newly synthesized polypeptides through the nascent peptide exit tunnel of the bacterial ribosome. Recent data challenged this view by showing that macrolide antibiotics can differentially a...
ORGANISM(S): Escherichia coli BW25113 
2014-11-03 | E-GEOD-61619 | biostudies-arrayexpress
TranscriptomicsTranscriptional profile in macrolide susceptible and resistant Campylobacter jejuni
Campylobacter jejuni is a major zoonotic pathogen transmitted to humans via the food chain. C. jejuni is prevalent in chickens, a natural reservoir for this pathogenic organism. Due to the importance of macrolide antibiotics in clinical therapy of human campylobacteriosis, development of macrolide r...
ORGANISM(S): Campylobacter jejuni 
2011-11-02 | E-GEOD-33330 | biostudies-arrayexpress
OtherThe general mode of translation inhibition by macrolide antibiotics
Macrolides are clinically important antibiotics thought to inhibit bacterial growth by impeding the passage of newly synthesized polypeptides through the nascent peptide exit tunnel of the bacterial ribosome. Recent data challenged this view by showing that macrolide antibiotics can differentially a...
ORGANISM(S): Escherichia coli BW25113 
2014-11-03 | GSE61619 | GEO
GenomicsContext-specific action of macrolide antibiotics on the eukaryotic ribosome
Context-specific action of macrolide antibiotics on the eukaryotic ribosome
PRJNA689836 | ENA
TranscriptomicsContext-specific action of macrolide antibiotics on the eukaryotic ribosome
80S ribosomes of S.cerevisiae carry G2400A mutation in the 25S rRNA which makes them sensitive to macrolide antibiotics
ORGANISM(S): Saccharomyces cerevisiae 
2021-05-25 | GSE164275 | GEO
UnknownThe general mode of translation inhibition by macrolide antibiotics.
Not available
S-EPMC4234590 | biostudies-literature
UnknownSpectrophotometric Investigations of Macrolide Antibiotics: A Brief Review.
Not available
S-EPMC4644142 | biostudies-literature
UnknownMacrolide antibiotics and the risk of ventricular arrhythmia in older adults.
Not available
S-EPMC4835295 | biostudies-literature
Sort   by:  
 Page size